Literature DB >> 12786633

Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population-based study at three time points.

J S Kalantar1, G R Locke, N J Talley, A R Zinsmeister, S L Fett, L J Melton.   

Abstract

BACKGROUND: We tested the hypothesis that subjects with relatives who suffered from abdominal pain or bowel dysfunction would be at an increased risk of more persistent irritable bowel syndrome.
METHODS: A valid, self-report questionnaire was mailed to an age- and gender-stratified random sample of residents, aged 30-64 years, in Olmsted County, MN, USA, on three occasions over a 4-year period. Persistent irritable bowel syndrome was defined as the presence of irritable bowel syndrome on at least two of the three surveys, and fluctuating irritable bowel syndrome was defined as the presence of irritable bowel syndrome on only one of the surveys.
RESULTS: Subjects were less likely to have persistent irritable bowel syndrome over the age of 50 years [odds ratio (OR), 0.20; 95% confidence interval (CI), 0.09, 0.47]. A positive family history was reported by 23%. A family history of gastrointestinal symptoms was independently associated with persistent irritable bowel syndrome (vs. no irritable bowel syndrome: OR, 2.5; 95% CI, 1.3, 4.9) and fluctuating irritable bowel syndrome (vs. no irritable bowel syndrome: OR, 2.4; 95% CI, 1.3, 4.4). However, subjects reporting a positive family history were not more likely to report persistent vs. fluctuating irritable bowel syndrome (OR, 1.2; 95% CI, 0.5, 2.9). The use of non-steroidal anti-inflammatory drugs (OR, 2.3; 95% CI, 1.2, 4.3) and a history of food sensitivity (OR, 3.6; 95% CI, 1.9, 6.9) were the only other predictors of persistent irritable bowel syndrome.
CONCLUSIONS: A history of abdominal pain or bowel troubles in first-degree relatives appears to be independently associated with both persistent and fluctuating irritable bowel syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12786633     DOI: 10.1046/j.1365-2036.2003.01591.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  4 in total

Review 1.  Cholecystectomy for biliary dyskinesia: how did we get there?

Authors:  Klaus Bielefeldt; Shreyas Saligram; Susan L Zickmund; Anwar Dudekula; Mojtaba Olyaee; Dhiraj Yadav
Journal:  Dig Dis Sci       Date:  2014-09-06       Impact factor: 3.199

2.  Intestinal permeability in irritable bowel syndrome patients: effects of NSAIDs.

Authors:  Angèle P M Kerckhoffs; Louis M A Akkermans; Martin B M de Smet; Marc G H Besselink; Falco Hietbrink; Imke H Bartelink; Wim B Busschers; Melvin Samsom; Willem Renooij
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

Review 3.  Ethnic differences in genetic polymorphism associated with irritable bowel syndrome.

Authors:  Qi-Yun Xiao; Xiu-Cai Fang; Xiao-Qing Li; Gui-Jun Fei
Journal:  World J Gastroenterol       Date:  2020-05-07       Impact factor: 5.742

4.  Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study.

Authors:  Daniel Keszthelyi; Gwen H Dackus; Gwen M Masclee; Joanna W Kruimel; Ad A M Masclee
Journal:  BMC Gastroenterol       Date:  2012-09-05       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.